What should convince a clinician of disease modification in Alzheimer's disease clinical trials? [PDF]
Hazan J, Liu KY, Howard R.
europepmc +1 more source
Comment on 'Factors associated with depressive symptoms among adolescents in Indonesia: A cross-sectional study of results from the Indonesia Family Life Survey'. [PDF]
Taşpolat ER.
europepmc +1 more source
The Impact of Indirect Transport to a Trauma Centre on Survival for Major Trauma Patients: A National Propensity-Adjusted Observational Study. [PDF]
Davie G +10 more
europepmc +1 more source
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study. [PDF]
Montalban X +15 more
europepmc +1 more source
A Compact Multiband Shark-Fin Antenna for Integrated V2X Communication Systems. [PDF]
Ding X, Zha W, Feng B, Ou Y, Sim CY.
europepmc +1 more source
Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's disease. [PDF]
Shulman M +16 more
europepmc +1 more source
Beyond patient education: Caregiver and family education on improving post-stroke quality of life. [PDF]
Taşpolat EK, Coşkun E.
europepmc +1 more source
Response to LTE "Bridging the Gap Between Patient Experience and System-Level Review: A Call for Discipline-Specific Communication in Hospital-to-Home Transitions. [PDF]
van Grootel J +8 more
europepmc +1 more source
Quality of life for pediatric patients with short bowel syndrome-associated intestinal failure treated with teduglutide. [PDF]
Wendel D +9 more
europepmc +1 more source

